ConductScience.org, home

Library / Genes

TET1: tet methylcytosine dioxygenase 1

1 protein, 82 patents, 0 drugs, 0 trials, 2,675 NIH grants and 4,878 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolTET1HGNC
Nametet methylcytosine dioxygenase 1HGNC
NCBI Gene ID80312NCBI Gene
HGNC IDHGNC:29484HGNC
EnsemblENSG00000138336NCBI Gene
AliasesCXXC6, KIAA1676, LCX, bA119F7.1NCBI Gene
Typeprotein-codingNCBI Gene

Proteins 1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource
Q8NFU7Methylcytosine dioxygenase TET12,1361Ensembl, GeneID, HGNCUniProt

Patents 82

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
WO 2026143185 A12026-07-02368Q8NFU7Espacenet
WO 2026015647 A12026-01-15196Q8NFU7Espacenet
JP 2026004568 A2026-01-1466819Q8NFU7Espacenet
WO 2025254779 A12025-12-111Q8NFU7Espacenet
US 12467082 B22025-11-1127Q8NFU7Espacenet
EP 4641201 A22025-10-299587Q8NFU7Espacenet
EP 4641202 A22025-10-295594Q8NFU7Espacenet
JP 2025147176 A2025-10-0615748Q8NFU7Espacenet
JP 2025531268 A2025-09-19260Q8NFU7Espacenet
JP 2025118716 A2025-08-1322Q8NFU7Espacenet

Drugs 0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource

Trials 0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource

NIH grants 2675

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
P30CA008748Cancer Center Support Grant302,025NIH's project files
R01HG006827Labeling and sequencing of 5hmC and 5mC in DNA-Renewal212,025NIH's project files
P30CA016672Cancer Center Support Grant182,025NIH's project files
R35CA210043The TET-DNMT-ASXL1-OGT axis: relevance to clonal hematopoiesis, heterochromatin integrity and cancer102,025NIH's project files
P30CA033572Cancer Center Support Grant82,025NIH's project files
P30CA125123Baylor College of Medicine Cancer Center - Cancer Center Support Grant72,025NIH's project files
P50AA022538Center for Alcohol Research in Epigenetics72,025NIH's project files
P30CA015083Mayo Clinic Comprehensive Cancer Center Support Grant62,025NIH's project files
P30CA016086Cancer Center Support Grant62,025NIH's project files
P30CA023168Cancer Center Support Grant62,025NIH's project files

Papers 4878

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42801306PubTator, text miningPubMed
42786170PubTator, text miningPubMed
42779800PubTator, text miningPubMed
42778210PubTator, text miningPubMed
42753018PubTator, text miningPubMed
42747979PubTator, text miningPubMed
42695671PubTator, text miningPubMed
42680856PubTator, text miningPubMed
42665721PubTator, text miningPubMed
42664975PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license